Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 279847, 9 pages
http://dx.doi.org/10.1155/2013/279847
Research Article

Sivelestat Attenuates Myocardial Reperfusion Injury during Brief Low Flow Postischemic Infusion

1Department of Emergency Medicine, The Davis Heart Lung Research Institute, The Ohio State University Wexner Medical Center, 750 Prior Hall, 376 W. 10th Avenue, Columbus, OH 43210, USA
2The Division of Cardiovascular Medicine, The Davis Heart Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA

Received 5 March 2013; Accepted 13 April 2013

Academic Editor: Narasimham L. Parinandi

Copyright © 2013 Sverre E. Aune et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. T. Turer and J. A. Hill, “Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy,” American Journal of Cardiology, vol. 106, no. 3, pp. 360–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Yannopoulos, S. McKnite, T. P. Aufderheide et al., “Effects of incomplete chest wall decompression during cardiopulmonary resuscitation on coronary and cerebral perfusion pressures in a porcine model of cardiac arrest,” Resuscitation, vol. 64, no. 3, pp. 363–372, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Iwakura, H. Ito, S. Takiuchi et al., “Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction,” Circulation, vol. 94, no. 6, pp. 1269–1275, 1996. View at Google Scholar · View at Scopus
  4. E. R. Rosenkranz and G. D. Buckberg, “Myocardial protection during surgical coronary reperfusion,” Journal of the American College of Cardiology, vol. 1, no. 5, pp. 1235–1246, 1983. View at Google Scholar · View at Scopus
  5. M. Montagnana, G. Lippi, M. Franchini, G. Targher, and G. C. Guidi, “Sudden cardiac death: prevalence, pathogenesis, and prevention,” Annals of Medicine, vol. 40, no. 5, pp. 360–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. I. Silver, R. J. Murphy, C. F. Babbs, and L. A. Geddes, “Cardiac output during CPR: a comparison of two methods,” Critical Care Medicine, vol. 9, no. 5, pp. 419–420, 1981. View at Google Scholar · View at Scopus
  7. D. F. Gaieski, B. S. Abella, and M. Goyal, “CPR and postarrest care: overview, documentation, and databases,” Chest, vol. 141, no. 4, pp. 1082–1089, 2012. View at Publisher · View at Google Scholar
  8. F. Beyersdorf, “The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage,” Cardiovascular Research, vol. 83, no. 2, pp. 262–268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Downey and M. V. Cohen, “Why do we still not have cardioprotective drugs?” Circulation Journal, vol. 73, no. 7, pp. 1171–1177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Kawabata, M. Suzuki, M. Sugitani, K. Imaki, M. Toda, and T. Miyamoto, “ONO-5046, a novel inhibitor of human neutrophil elastase,” Biochemical and Biophysical Research Communications, vol. 177, no. 2, pp. 814–820, 1991. View at Google Scholar · View at Scopus
  11. D. Akiyama, T. Hara, O. Yoshitomi, T. Maekawa, S. Cho, and K. Sumikawa, “Postischemic infusion of sivelestat sodium hydrate, a selective neutrophil elastase inhibitor, protects against myocardial stunning in swine,” Journal of Anesthesia, vol. 24, no. 4, pp. 575–581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Toyama, F. Hatori, A. Shimizu, and T. Takagi, “A neutrophil elastase inhibitor, sivelestat, improved respiratory and cardiac function in pediatric cardiovascular surgery with cardiopulmonary bypass,” Journal of Anesthesia, vol. 22, no. 4, pp. 341–346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Ueno, Y. Moriyama, R. Toda et al., “Effect of a neutrophil elastase inhibitor (ONO-5046 Na) on ischemia/reperfusion injury using the left-sided heterotopic canine heart transplantation model,” Journal of Heart and Lung Transplantation, vol. 20, no. 8, pp. 889–896, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kambe, R. Bessho, M. Fujii, M. Ochi, and K. Shimizu, “Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia,” Interactive Cardiovascular and Thoracic Surgery, vol. 8, no. 6, pp. 629–634, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. R. Lucchesi, “Myocardial ischemia, reperfusion and free radical injury,” American Journal of Cardiology, vol. 65, no. 19, pp. 14I–23I, 1990. View at Google Scholar · View at Scopus
  16. R. Bolli, “Oxygen-derived free radicals and postischemic myocardial dysfunction (“stunned myocardium”),” Journal of the American College of Cardiology, vol. 12, no. 1, pp. 239–249, 1988. View at Google Scholar · View at Scopus
  17. P. Kuppusamy and J. L. Zweier, “Characterization of free radical generation by xanthine oxidase. Evidence for hydroxyl radical generation,” Journal of Biological Chemistry, vol. 264, no. 17, pp. 9880–9884, 1989. View at Google Scholar · View at Scopus
  18. V. K. Kutala, M. Khan, M. G. Angelos, and P. Kuppusamy, “Role of oxygen in postischemic myocardial injury,” Antioxidants and Redox Signaling, vol. 9, no. 8, pp. 1193–1206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. G. Birukov, “Cyclic stretch, reactive oxygen species, and vascular remodeling,” Antioxidants and Redox Signaling, vol. 11, no. 7, pp. 1651–1667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. X. L. Chen, Q. Zhang, R. Zhao, X. Ding, P. E. Tummala, and R. M. Medford, “Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-α in endothelial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 2, pp. 573–580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Spiekermann, U. Landmesser, S. Dikalov et al., “Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation,” Circulation, vol. 107, no. 10, pp. 1383–1389, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” Journal of Physiology, vol. 552, no. 2, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. E. Quillen, F. W. Sellke, L. A. Brooks, and D. G. Harrison, “Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries,” Circulation, vol. 82, no. 2, pp. 586–594, 1990. View at Google Scholar · View at Scopus
  24. J. L. Zweier and M. A. H. Talukder, “The role of oxidants and free radicals in reperfusion injury,” Cardiovascular Research, vol. 70, no. 2, pp. 181–190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. D. Stoner, T. L. Clanton, S. E. Aune, and M. G. Angelos, “O2 delivery and redox state are determinants of compartment-specific reactive O2 species in myocardial reperfusion,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 1, pp. H109–H116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Ferrera, S. Benhabbouche, J. C. Bopassa, B. Li, and M. Ovize, “One hour reperfusion is enough to assess function and infarct size with ttc staining in langendorff rat model,” Cardiovascular Drugs and Therapy, vol. 23, no. 4, pp. 327–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. E. C. Dinovo, D. S. Miyada, and R. M. Nakamura, “Evaluation of direct and indirect coupled enzyme assay systems for measurement of creatine kinase activity,” Clinical Chemistry, vol. 19, no. 9, pp. 994–997, 1973. View at Google Scholar · View at Scopus
  28. M. Khan, S. Meduru, M. Mostafa, S. Khan, K. Hideg, and P. Kuppusamy, “Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and akt signaling,” Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 2, pp. 421–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. V. P. Bindokas, J. Jordán, C. C. Lee, and R. J. Miller, “Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine,” Journal of Neuroscience, vol. 16, no. 4, pp. 1324–1336, 1996. View at Google Scholar · View at Scopus
  30. F. Kanemitsu and T. Okigaki, “Clinical application of subforms of creatine kinase MM and macro creatine kinases,” Journal of Chromatography—Biomedical Applications, vol. 526, no. 2, pp. 423–438, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. D. Wang, J. Pernow, P. O. Sjöquist, and L. Rydén, “Pharmacological possibilities for protection against myocardial reperfusion injury,” Cardiovascular Research, vol. 55, no. 1, pp. 25–37, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Okajima, N. Harada, M. Uchiba, and M. Mori, “Neutrophil elastase contributes to the development of ischemia-reperfusion- induced liver injury by decreasing endothelial production of prostacyclin in rats,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 287, no. 6, pp. G1116–G1123, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Takayama and K. Uchida, “Epithelium-dependent and -independent inhibitory effects of sivelestat, a neutrophil elastase inhibitor, on substance P-induced contraction of airway smooth muscle in lipopolysaccharide-treated guinea-pigs,” Journal of Smooth Muscle Research, vol. 41, no. 5, pp. 257–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Maeda, S. Mitsumizo, F. Guo et al., “Sivelestat relaxes porcine coronary artery via inhibition of Ca2+ sensitization induced by a receptor agonist,” Journal of Cardiovascular Pharmacology, vol. 51, no. 5, pp. 476–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Amemori, Y. Maeda, A. Torikai, and M. Nakashima, “Sivelestat relaxes vascular smooth muscle contraction in human gastric arteries,” Journal of Physiology and Biochemistry, vol. 64, no. 4, pp. 589–593, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Vásquez-Vivar, B. Kalyanaraman, P. Martásek et al., “Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9220–9225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. A. L. Moens, R. Kietadisorn, J. Y. Lin, and D. Kass, “Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin,” Journal of Molecular and Cellular Cardiology, vol. 51, pp. 559–563, 2011. View at Publisher · View at Google Scholar
  38. H. Kin, Z. Q. Zhao, H. Y. Sun et al., “Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion,” Cardiovascular Research, vol. 62, no. 1, pp. 74–85, 2004. View at Publisher · View at Google Scholar · View at Scopus